---
title: "NanoVibronix | 10-Q: FY2025 Q3 Revenue: USD 722 K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265987480.md"
datetime: "2025-11-14T21:44:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265987480.md)
  - [en](https://longbridge.com/en/news/265987480.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265987480.md)
---

# NanoVibronix | 10-Q: FY2025 Q3 Revenue: USD 722 K

Revenue: As of FY2025 Q3, the actual value is USD 722 K.

EPS: As of FY2025 Q3, the actual value is USD -0.91.

EBIT: As of FY2025 Q3, the actual value is USD 598 K.

### Segment Revenue

-   **NanoVibronix**: $1,738 thousand for the nine months ended September 30, 2025.
-   **ENvue**: $503 thousand for the nine months ended September 30, 2025.

### Operational Metrics

-   **Gross Profit**: $523 thousand for the nine months ended September 30, 2025, compared to $1,225 thousand for the same period in 2024, a decrease of 57%.
-   **Operating Loss**: $8,075 thousand for the nine months ended September 30, 2025, compared to $2,212 thousand for the same period in 2024.

### Cash Flow

-   **Net Cash Used in Operating Activities**: - $6,696 thousand for the nine months ended September 30, 2025.
-   **Net Cash Provided by Financing Activities**: $12,820 thousand for the nine months ended September 30, 2025.

### Unique Metrics

-   **Goodwill**: $38,631 thousand as of September 30, 2025, resulting from the ENvue merger.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to continue its operations through its subsidiaries, focusing on non-invasive biological response-activating devices and enteral feeding medical devices. The company expects to incur future net losses and will depend on raising additional funds to support its operations.
-   **Non-Core Business**: The company has identified inaccuracies in its 510(k) application for the PainShield MD Plus product and has decided to halt future sales of this product.

### Related Stocks

- [NAOV.US](https://longbridge.com/en/quote/NAOV.US.md)
- [FEED.US](https://longbridge.com/en/quote/FEED.US.md)

## Related News & Research

- [Zefiro Completes Fiscal Q3 2026 with Strong Business Performance During the Calendar Months of January-March | ZEFIF Stock News](https://longbridge.com/en/news/282391619.md)
- [JIADE LIMITED Announces Fiscal Year 2025 Financial Results | JDZG Stock News](https://longbridge.com/en/news/282388641.md)
- [Richardson Electronics reports Q3 net income $0.9M, revenue $55.5M; Board declares $0.06 dividend](https://longbridge.com/en/news/282095566.md)
- [Better Warren Buffett Stock: American Express vs. Visa](https://longbridge.com/en/news/282443365.md)
- [Resources Connection Q3 revenue falls on lower billable hours](https://longbridge.com/en/news/282091678.md)